BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28263967)

  • 1. Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization.
    Yang JM; Schiapparelli P; Nguyen HN; Igarashi A; Zhang Q; Abbadi S; Amzel LM; Sesaki H; Quiñones-Hinojosa A; Iijima M
    Oncogene; 2017 Jun; 36(26):3673-3685. PubMed ID: 28263967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targeting of cancers with loss of PTEN function.
    Dillon LM; Miller TW
    Curr Drug Targets; 2014 Jan; 15(1):65-79. PubMed ID: 24387334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering PTEN function: membrane association and activity.
    Yang JM; Nguyen HN; Sesaki H; Devreotes PN; Iijima M
    Methods; 2015 May; 77-78():119-24. PubMed ID: 25448479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamic simulation and functional analysis of pathogenic PTEN mutations in glioblastoma.
    Cetintas VB; Duzgun Z; Akalin T; Ozgiray E; Dogan E; Yildirim Z; Akinturk N; Biceroglu H; Ertan Y; Kosova B
    J Biomol Struct Dyn; 2023; 41(21):11471-11483. PubMed ID: 36591942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTENβ is an alternatively translated isoform of PTEN that regulates rDNA transcription.
    Liang H; Chen X; Yin Q; Ruan D; Zhao X; Zhang C; McNutt MA; Yin Y
    Nat Commun; 2017 Mar; 8():14771. PubMed ID: 28332494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network Analyses of Brain Tumor Patients' Multiomic Data Reveals Pharmacological Opportunities to Alter Cell State Transitions.
    Bumbaca B; Birtwistle MR; Gallo JM
    bioRxiv; 2024 May; ():. PubMed ID: 38766170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Curcumin in Cancer: A Focus on the PI3K/Akt Pathway.
    Zoi V; Kyritsis AP; Galani V; Lazari D; Sioka C; Voulgaris S; Alexiou GA
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic insights and the clinical prospects of targeted therapies for glioblastoma: a comprehensive review.
    Shen Y; Thng DKH; Wong ALA; Toh TB
    Exp Hematol Oncol; 2024 Apr; 13(1):40. PubMed ID: 38615034
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Travis G; McGowan EM; Simpson AM; Marsh DJ; Nassif NT
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid biopsy: creating opportunities in brain space.
    Trivedi R; Bhat KP
    Br J Cancer; 2023 Nov; 129(11):1727-1746. PubMed ID: 37752289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Slicing' glioblastoma drivers with the Swiss cheese model.
    Teran Pumar OY; Lathia JD; Watson DC; Bayik D
    Trends Cancer; 2024 Jan; 10(1):15-27. PubMed ID: 37625928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel sights on therapeutic, prognostic, and diagnostics aspects of non-coding RNAs in glioblastoma multiforme.
    Mekala JR; Adusumilli K; Chamarthy S; Angirekula HSR
    Metab Brain Dis; 2023 Aug; 38(6):1801-1829. PubMed ID: 37249862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the detection of glioblastoma, from imaging-based methods to proteomics and biosensors: A narrative review.
    Hosseini A; Ashraf H; Rahimi F; Alipourfard I; Alivirdiloo V; Hashemi B; Yazdani Y; Ghazi F; Eslami M; Ameri Shah Reza M; Dadashpour M
    Cancer Cell Int; 2023 May; 23(1):98. PubMed ID: 37210528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semisynthetic Approach to the Analysis of Tumor Suppressor PTEN Ubiquitination.
    Iwase R; Dempsey DR; Whedon SD; Jiang H; Palanski BA; Deng B; Cole PA
    J Am Chem Soc; 2023 Mar; 145(11):6039-6044. PubMed ID: 36897111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear PTEN's Functions in Suppressing Tumorigenesis: Implications for Rare Cancers.
    Langdon CG
    Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830628
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional analysis of PTEN variants of unknown significance from PHTS patients unveils complex patterns of PTEN biological activity in disease.
    Torices L; Mingo J; Rodríguez-Escudero I; Fernández-Acero T; Luna S; Nunes-Xavier CE; López JI; Mercadillo F; Currás M; Urioste M; Molina M; Cid VJ; Pulido R
    Eur J Hum Genet; 2023 May; 31(5):568-577. PubMed ID: 36543932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linear ubiquitination of PTEN impairs its function to promote prostate cancer progression.
    Guo Y; He J; Zhang H; Chen R; Li L; Liu X; Huang C; Qiang Z; Zhou Z; Wang Y; Huang J; Zhao X; Zheng J; Chen GQ; Yu J
    Oncogene; 2022 Oct; 41(44):4877-4892. PubMed ID: 36192478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Roles of Non-proteolytic Ubiquitination in Tumorigenesis.
    Yin X; Liu Q; Liu F; Tian X; Yan T; Han J; Jiang S
    Front Cell Dev Biol; 2022; 10():944460. PubMed ID: 35874839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of OTUD5 in non-small cell lung cancer cell proliferation, invasion, and migration.
    Li X; Lu B; Zhang L; Yang J; Cheng Y; Yan D
    Bosn J Basic Med Sci; 2022 Oct; 22(6):901-911. PubMed ID: 35765958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoubiquitination in Homeostasis and Cancer.
    Chen Y; Zhou D; Yao Y; Sun Y; Yao F; Ma L
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.